MICHAEL VOLK to Quality-Adjusted Life Years
This is a "connection" page, showing publications MICHAEL VOLK has written about Quality-Adjusted Life Years.
Connection Strength
0.051
-
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation. 2017 05; 101(5):1001-1008.
Score: 0.032
-
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology. 2010 Jan; 51(1):165-73.
Score: 0.019